An educational scholarship of Mundipharma has enabled the creation of the clinical and translational group in diabetes (CTD), an initiative that aims to reduce the gap between the advances in research in this area and the effective application of these in the patient.
The unit is coordinated by the Head of the Department of Endocrinology and Clinical Nutrition in Quirónsalud (Madrid), Dr. Esteban Jódar, the head of the University of Research in Diabetes and Metabolism of the Institution of Recerca University Hospital Vall d'Hebron (Barcelona),Dr. Rafael Simó and the member of the Endocrinology and Nutrition Service of the Univesitary Clinical Hospital of Vaencia, Dr. Francisco Javier Ampudia-Blasco.
"It is an initiative arising from a group of professionals with both clinical and researcher activity in this area, concerned with the translation of knowledge from basic science to the daily clinic that, in the case of diabetes, is experiencing a true revolution,"Dr. Jódar has indicated.
First, they contemplate continuous and multidisciplinary training in diabetes mellitus, a disease with great prevalence and consumes a large amount of health resources.
"Generate quality knowledge, involving experts from various specialties such as endocrinology or primary care, will allow a more efficient treatment of people with diabetes," said Dr. Ampudia-Blasco.
In addition, the group has the claim to generate training elements based on group work.He also wants to be completed as a scientific debate forum.
Among the first actions to be carried out, the group has set the celebration in Madrid of a meeting in September that intends to realize the first issues of review and debate and will focus on areas such as nephrological and cardiovascular diseases in people with diabetes.